{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:09:06Z","timestamp":1768457346360,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ygyno.2023.08.018","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T17:59:10Z","timestamp":1694109550000},"page":"142-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["High-dose (60\u00a0Gy) intensity-modulated radiotherapy with concurrent weekly cisplatin followed by intracavitary radiation in locally advanced cervical cancer: A phase II prospective clinical trial"],"prefix":"10.1016","volume":"177","author":[{"given":"Hyo Chun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Won","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Chun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo Hee","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2023.08.018_bb0005","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","article-title":"Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma","volume":"340","author":"Keys","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0010","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","article-title":"Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer","volume":"340","author":"Morris","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0015","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer","volume":"340","author":"Rose","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0020","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJM199904153401509","article-title":"Improved treatment for cervical cancer--concurrent chemotherapy and radiotherapy","volume":"340","author":"Thomas","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0025","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.1999.17.5.1339","article-title":"Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a gynecologic oncology group and southwest oncology group study","volume":"17","author":"Whitney","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0030","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0035","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1200\/JCO.2004.07.197","article-title":"Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01","volume":"22","author":"Eifel","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0040","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1200\/JCO.2006.09.4532","article-title":"Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a gynecologic oncology group study","volume":"25","author":"Rose","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"503","key":"10.1016\/j.ygyno.2023.08.018_bb0045","first-page":"e1","article-title":"Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a gynecologic oncology group trial","volume":"197","author":"Stehman","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0050","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1200\/JCO.2007.10.8324","article-title":"Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions","volume":"25","author":"Monk","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0055","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ijrobp.2006.12.013","article-title":"Practice patterns of radiotherapy in cervical cancer among member groups of the gynecologic cancer intergroup (GCIG)","volume":"68","author":"Gaffney","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0060","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ijrobp.2010.11.005","article-title":"ACR appropriateness criteria\u00ae on advanced cervical cancer expert panel on radiation oncology-gynecology","volume":"81","author":"Gaffney","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2023.08.018_bb0065","first-page":"S153","article-title":"Principles of radiation therapy in low-resource and well-developed settings, with particular reference to cervical cancer","volume":"131","author":"Shrivastava","year":"2015","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0070","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ijrobp.2009.06.041","article-title":"Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer","volume":"77","author":"Kidd","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ygyno.2011.12.432","article-title":"Intensity-modulated radiation therapy for advanced cervical cancer: a comparison of dosimetric and clinical outcomes with conventional radiotherapy","volume":"125","author":"Du","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0080","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ijrobp.2013.06.2059","article-title":"Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study","volume":"87","author":"Gandhi","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0085","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/j.ijrobp.2010.10.066","article-title":"Helical tomotherapy with simultaneous integrated boost after laparoscopic staging in patients with cervical cancer: analysis of feasibility and early toxicity","volume":"82","author":"Marnitz","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0090","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13014-015-0551-0","article-title":"Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer","volume":"10","author":"Cihoric","year":"2015","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0095","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ygyno.2017.08.029","article-title":"Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: a multi-institutional retrospective analysis of KROG 16-01","volume":"147","author":"Lee","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0100","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ygyno.2013.10.014","article-title":"A novel diagnostic criterion for lymph node metastasis in cervical cancer using multi-detector computed tomography","volume":"131","author":"Yamanoi","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology","volume":"78","author":"P\u00f6tter","year":"2006","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0110","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijrobp.2006.12.023","article-title":"Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer","volume":"68","author":"Beriwal","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0115","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12094-015-1336-5","article-title":"Radiotherapy dose escalation with concurrent chemotherapy in locally advanced cervix cancer is feasible","volume":"18","author":"Hegazy","year":"2016","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0120","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/cncr.27652","article-title":"The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy","volume":"119","author":"Song","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2023.08.018_bb0125","article-title":"Dose-escalated intensity-modulated radiotherapy for the management of locally advanced cervical cancer","volume":"14","author":"Shewalkar","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.ygyno.2023.08.018_bb0130","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(97)02250-2","article-title":"Randomised study of radical surgery versus radiotherapy for stage Ib\u2013II cervical cancer","volume":"350","author":"Landoni","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2023.08.018_bb0135","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13014-021-01818-1","article-title":"High dose simultaneous integrated boost for node positive cervical cancer","volume":"16","author":"Jayatilakebanda","year":"2021","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0140","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13014-015-0551-0","article-title":"Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer","volume":"10","author":"Cihoric","year":"2015","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0145","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clon.2015.10.008","article-title":"45 or 50 Gy, which is the optimal radiotherapy pelvic dose in locally advanced cervical cancer in the perspective of reaching magnetic resonance image-guided adaptive brachytherapy planning aims?","volume":"28","author":"Mazeron","year":"2016","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"key":"10.1016\/j.ygyno.2023.08.018_bb0150","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0155","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.21873\/invivo.12026","article-title":"Hysterectomy for recurrent\/residual cervical cancer following definitive radiotherapy","volume":"34","author":"Nakasone","year":"2020","journal-title":"In Vivo"},{"key":"10.1016\/j.ygyno.2023.08.018_bb0160","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ijgo.12284","article-title":"Radical hysterectomy after radiotherapy for recurrent or persistent cervical cancer","volume":"139","author":"Mabuchi","year":"2017","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2023.08.018_bb0165","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3857\/roj.2022.00199","article-title":"Dosimetric analysis of intracavitary brachytherapy applicators: a practical study","volume":"40","author":"Khan","year":"2022","journal-title":"Radiat. Oncol. J."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823014609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823014609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:06:01Z","timestamp":1758773161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823014609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":33,"alternative-id":["S0090825823014609"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.08.018","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose (60\u00a0Gy) intensity-modulated radiotherapy with concurrent weekly cisplatin followed by intracavitary radiation in locally advanced cervical cancer: A phase II prospective clinical trial","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}